Additionally, B2M has functionally been implicated in prostate cancer as its over-expression in cancer cells induced rapid tumour growth in bone, while disrupting B2M signaling by specific small interfering RNA produced a regression of previously established prostate tumours [41]. The gene discussed is B2M; the disease is prostate carcinoma.